Now available!
Omnipod® 5 Automated Insulin Delivery System

Omnipod® 5
Tubeless, automatic insulin adjustments

Omnipod 5, the first and only tubeless, automated insulin delivery system to integrate with Dexcom G6, is now available. Omnipod 5 helps simplify life with diabetes: no multiple daily injections, tubes, or fingersticks* necessary!  

  • Cleared for people with type 1 diabetes aged 6 years and older 

  • Helps keep you in range day and night¥ 

  • Monitor your glucose levels and insulin dosing all with the option for full control right from your compatible smartphone

  • Just like Omnipod DASH®️, it includes a waterproof tubeless insulin Pod that can be worn almost anywhere you’d inject insulin.  

  • Each Pod still lets you trade multiple daily injections for up to 3 days (72 hours) of continuous insulin delivery. 

Now, the Pod is automated, CGM integrated, and highly anticipated—helping to simplifying life in so many ways. 

*Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
†For a list of compatible smartphone devices visit omnipod.com/compatibility.
‡The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Controller is not waterproof.

3 Simple Parts

To the Omnipod 5 Automated Insulin Delivery System

Omnipod 5 App*
Take full control of the Pod from the Omnipod 5 App on a compatible smartphone* or use the free Controller, included at no additional charge with your first prescription for the Omnipod 5 Intro Kit.

*For a list of compatible smartphone devices visit omnipod.com/compatibility.

Pod
Tubeless, wearable and waterproof, this state-of-the-art Pod, with built in SmartAdjust™ technology, sits right on your body and automatically adjusts insulin delivery for up to 3 days or 72 hours.

Dexcom® G6 CGM  System 
Continuously sends glucose readings to the Pod, so you can get real-time data without the fingersticks*. A separate prescription is required for the Dexcom G6 CGM. The Dexcom G6 is sold separately. The Dexcom G6 app is required for use with the Omnipod 5 System. 

*Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match CGM sensor readings.

Always adjusting, so you don’t have to

With SmartAdjust technology, Omnipod 5 and the Dexcom G6 CGM* are in constant communication, enabling automatic insulin adjustments to help improve time in range.¥

* Dexcom G6 App is needed to control the G6 CGM

What’s New:

SmartAdjust™ technology

Every 5 minutes, the system automatically increases, decreases, or pauses insulin delivery based on your customized target glucose—helping to protect against highs and lows¥, day and night.

Activity feature

Activity with a few finger taps. When using the Activity feature, Omnipod 5 reduces insulin delivery when glucose typically goes low, like when exercising.

SmartBolus calculator

The only AID system with a built-in bolus calculator that automatically incorporates your CGM data and trend, so you don’t have to.

What’s Still True:

No more multiple daily injections

No more multiple daily injections when managing insulin.

Waterproof* device

Wear the Pod in the shower, the ocean, or running in the rain.

*The Pod has an IP28 rating for up to 25 feet for 60 minutes.

No tubes to get in the way

Walk freely through every open door, leaving doorknobs in your dust. No belts, fanny packs, or pockets required.

 

Omnipod 5 has definitely allowed me to focus more on life and less on type 1 diabetes.

Gracie
Podder

 

Control it all from a compatible smartphone

To simplify things even more, you can control the Omnipod 5 System from a compatible smartphone through the Omnipod 5 App. With the Pod and CGM continuously talking, they’ll do most of the work automatically, but, when you need to, you can control your insulin delivery, give yourself a mealtime dose, and easily share data (see full list of compatible smartphones).

If your phone isn’t compatible, you can use the free Omnipod 5 Controller, included at no additional charge with your first prescription for the Omnipod 5 Intro Kit.

Test out Pod Therapy today

Ready to experience tubeless freedom? Get started online with a no-commitment, free benefits check. Simply fill out the form and one of our Omnipod specialists will be in touch with next steps. 

Looking for more information about Omnipod 5?

¥. Brown S. et al. Diabetes Care. 2021;44:1630-1640. Prospective pivotal trial in 240 participants with T1D aged 6 - 70 yrs. Study included a 14-day standard therapy (ST) phase followed by a 3-month Omnipod 5 hybrid closed-loop (HCL) phase. Mean time in range (70-180mg/dL) in adults/adolescents and children as measured by CGM: ST = 64.7%, 3-mo Omnipod 5 = 73.9%, P<0.0001; ST = 52.5%, 3-mo Omnipod 5 = 68.0%, P<0.0001, respectively. Mean time > 180 mg/dL (12AM-6AM) as in adults/adolescents and children, ST vs. 3-mo Omnipod 5: 32.1% vs. 20.7%; 42.2% vs. 20.7%, P<0.0001, respectively. Mean time >180 mg/dL (6AM -12AM) in adults/adolescents and children, ST vs. 3-mo Omnipod 5: 32.6% vs. 26.1%; 46.4% vs. 33.4%, P<0.0001, respectively. Median time in <70 mg/dL (12AM-6AM) in adults/adolescents and children, ST vs. 3-mo Omnipod 5: 2.07% vs. 0.82%,P<0.0001; 0.78% vs. 0.78%, P=0.0456, respectively. Median time <70 mg/dL (6AM-12AM) in adults/adolescents and children, ST vs. 3-mo Omnipod 5: 1.91% vs. 1.08%, P<0.0001; 1.17% vs. 1.62%, P=0.2545, respectively. Results measured by CGM.

Risk Statement
The Omnipod 5 Automated Insulin Delivery System is indicated for use by individuals with type 1 diabetes mellitus in persons 6 years of age and older. The Omnipod 5 System is intended for single patient, home use and requires a prescription. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, and Admelog®. 

The Omnipod 5 ACE Pump (Pod) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Omnipod 5 ACE Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. SmartAdjust™ technology is intended for use with compatible integrated continuous glucose monitors (iCGM) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and pause delivery of insulin based on current and predicted glucose values. The  Omnipod 5 SmartBolus Calculator is intended to calculate a suggested bolus dose based on user-entered carbohydrates, most recent sensor glucose value (or blood glucose reading if using fingerstick), rate of change of the sensor glucose (if applicable), insulin on board (IOB), and programmable correction factor, insulin to carbohydrate ratio, and target glucose value. 
 

WARNING: SmartAdjust technology should NOT be used by anyone under the age of 6 years old. SmartAdjust technology should also NOT be used in people who require less than 6 units of insulin per day as the safety of the technology has not been evaluated in this population. 

The Omnipod 5 System is NOT recommended for people who are unable to monitor glucose as recommended by their healthcare provider, are unable to maintain contact with their healthcare provider, are unable to use the Omnipod 5 System according to instructions, are taking hydroxyurea as it could lead to falsely elevated CGM values and result in over-delivery of insulin that can lead to severe hypoglycemia, and do NOT have adequate hearing and/or vision to allow recognition of all functions of the Omnipod 5 System, including alerts, alarms, and reminders. Device components including the Pod, CGM transmitter, and CGM sensor must be removed before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or diathermy treatment. In addition, the Controller and smartphone should be placed outside of the procedure room. Exposure to MRI, CT, or diathermy treatment can damage the components. Visit www.omnipod.com/safety for additional important safety information.


WARNING: DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.

Regional Disclaimer

Are you a resident of the United States?

Yes No

The content of the webpage that you are about to access is exclusively reserved for residents of the United States.

If you are a resident of the United States, please click 'Yes' to continue. If not, please click 'No' to exit and do not access the webpages. If you selected this country/language in error, you can go back to the previous page and select your country/language.

Thank you.